Cardarine 10mg/tab 30 Tablets by Vital Research

Usage

1. Define your goal phase — cutting or bulking — before selecting stack partners; Cardarine's role and complementary compounds differ between phases.
2. For a cutting stack, combine Cardarine 10 mg/day with Ostarine at your target dose; administer both compounds simultaneously each morning with water.
3. For a bulking stack, introduce Cardarine alongside LGD-4033 and RAD-140 from week one to establish the metabolic baseline before androgen-receptor agonists take effect.
4. Take the tablet at a consistent time daily; Cardarine's reported half-life of approximately 16–24 hours supports once-daily dosing for stable plasma levels.
5. Track cardiovascular markers and lipid panels at baseline and at mid-cycle (week 4) to monitor the metabolic impact within your stack context.
6. Plan post-cycle support according to the androgenic compounds in your stack — not Cardarine itself — since GW-501516 does not suppress the HPTA.

Warnings

Frequently asked questions

What SARM stack is best for a research cutting phase: Ostarine + Cardarine or something else?

Ostarine combined with Cardarine is the most widely referenced two-compound cutting protocol in the research literature. Ostarine preserves lean tissue by engaging skeletal-muscle androgen receptors during a caloric deficit, while Cardarine's PPARδ activation supports lipid catabolism. This pairing avoids receptor competition because the two compounds act on entirely different molecular targets, making it a mechanistically clean combination for cutting research.

Can LGD-4033 and RAD-140 be stacked together in a bulking protocol?

Both LGD-4033 and RAD-140 act on the androgen receptor, so stacking them layers androgenic stimulus from two compounds simultaneously. Research protocols that combine them typically run lower individual doses to manage suppression risk. Adding Cardarine to this bulking stack provides a non-androgenic metabolic layer — supporting lipid metabolism and cardiovascular parameters — without introducing additional androgen-receptor agonism.

How long should a SARM stack with Cardarine run before a break?

Most structured research protocols using Cardarine-inclusive stacks run 8–12 weeks, followed by an off period at least equal in length. The duration is primarily governed by the androgenic SARMs in the stack (Ostarine, LGD-4033, RAD-140), as these compounds are associated with hypothalamic-pituitary axis suppression. Cardarine itself does not suppress the HPTA, but stack duration should be planned around the most suppressive compound present.

Are Vital Research Cardarine 10mg tablets easy to split for lower-dose protocols?

The 10 mg tablet is already at the lower boundary of the dose range used in published GW-501516 research, so splitting is rarely necessary. Each tablet is compressed under GMP-aligned conditions with content-uniformity controls, meaning dose accuracy is consistent across all 30 tablets in the blister. Researchers who require sub-10 mg increments can split tablets, but the 10 mg unit suits most stack protocols as an unsplit dose.

How are Vital Research Cardarine tablets packaged and verified for quality?

Tablets are supplied in a 30-count blister unit with a traceable lot number linking each pack to its certificate of analysis. Quality release requires passing both HPLC potency testing and LAL endotoxin screening — results are documented per batch rather than per product line. Blister packaging provides physical protection and makes individual-dose integrity straightforward to maintain over the full 30-tablet supply. (2) angle_used

Manufacturer

Vital Research's product portfolio is structured around distinct compound categories — each line is formulated and released independently rather than bundled into combination products. The Cardarine line exemplifies this approach: GW-501516 is offered as a standalone tablet at a single precision dose, positioned as a stack component rather than an all-in-one solution. Portfolio integrity is maintained through individual batch certification — each SKU receives its own HPLC and LAL test report, ensuring that quality data is compound-specific rather than shared across product families. This architecture reflects Vital Research's design philosophy: research-grade inputs, documented outputs, and compound separation that gives researchers full control over stack composition.